¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"patient transfer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free flap transfer
    À¯¸®ÇÇÆÇÀüÀÌ(¼ú)
  • frontalis transfer
    À̸¶±Ù¿Å±è(¼ú), ÀüµÎ±ÙÀüÀÌ(¼ú)
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • gene transfer therapy
    À¯ÀüÀÚÀ̽Ŀä¹ý
  • gamete intrafallopian transfer
    »ý½Ä¼¼Æ÷Àڱðü³»À̽Ä, »ý½Ä¼¼Æ÷Àڱðü³»Àü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • magnetization transfer technique
    ÀÚ¼ºÈ­Àü´Þ±â¼ú
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • passive transfer
    ¼öµ¿Àü´Þ
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • tendon transfer
    ÈûÁÙÀüÀÌ(¼ú), °ÇÀüÀÌ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • direct transfer flap
    Á÷Á¢ÇÇÆÇ
  • electro transfer system
    ÀüÀÚÀü´Þ°è, ÀüÀÚ¿î¹Ýü
  • magnetization transfer effect
    ÀÚ±âÈ­Àü´ÞÈ¿°ú
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • free flap transfer
    À¯¸®ÇÇÆÇÀüÀÌ, À¯¸®ÇÇÆÇÀüÀ̼ú
  • frontalis transfer
    À̸¶±Ù¿Å±è¼ú, ÀüµÎ±ÙÀüÀ̼ú
  • transfer factor
    Àü´ÞÀÎÀÚ
  • transfer forceps
    Àü´ÞÁý°Ô, À̵¿°âÀÚ, Àü´Þ°âÀÚ
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • placenta transfer
    ŹÝÀüÀÌ, ŹÝÅë°ú
  • placental transfer
    ŹÝÀ̵¿.
  • placental transfer
    ŹÝÀ̵¿(÷ÃÚïì¹ÔÑ)
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • patient identification
    ȯÀÚÈ®ÀÎ
  • patient participation
    ȯÀÚ Âü¿©
  • patient performance index
    ȯÀÚȰµ¿°è¼ö
  • patient position
    ȯÀÚÀÇ ÀÚ¼¼
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient preparation
    ȯÀÚÁغñ
  • patient satisfaction
    ȯÀÚ¸¸Á·µµ.
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÀΰøÈ£Èí±â.
  • patient triggered ventilator
    ȯÀÚÀ¯¹ßÈ£Èí±â(ü´íºë¯Û¡û¼ýåÐï).
  • professional patient
    Àü¹®°¡ ȯÀÚ
  • safe conduct, for dying patient
    ¾ÈÁ¤À¯µµ(»ç¸ÁÀÚ¸¦ À§ÇÑ)
  • adoptive transfer
    ÀÎÀÔ(¸é¿ª)Àü´Þ(ìÚìýØóæ¹îîÓ¹).
  • adoptive transfer
    ÀÔ¾çÀü´Þ
  • afterimage transfer test
    ÀÜ»óÀüÀ̰˻ç
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • group transfer potential
    ¿øÀÚ´Ü ÀüÀÌ ÀüÀ§(ê«í­Ó¥ï®ì¹Úãëë)
  • infectious transfer
    °¨¿°¼º ÀÌÀü(Êïæøàõì¹ï®)
  • initiator transfer RNA
    °³½Ã(ËÒã·) Àü´Þ(îîÓ¹)RNA
  • isoacceptor transfer RNA
    µ¿Á¾¼ö³³Ã¼(ÔÒðúáôÒ¡ô÷) ÀüÀÌ(ï®ì¹)RNA
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
  • methionyl transfer RNA
    ¸ÞƼ¿À´Ñ Àü´Þ(îîÓ¹) RNA
  • methyl-poor transfer RNA
    °ú(Íû)¸ÞÆ¿ Àü´Þ(îîÓ¹)RNA
  • modulator transfer RNA
    Á¤Á¶ÀÚ(ïÚðàí­) Àü´Þ(îîÓ¹) RNA
  • noncollisional energy transfer
    ºñÃæµ¹(ÞªõúÔÍ)¿¡³ÊÁöÀü´Þ(îîÓ¹)
  • passive transfer
    ¼öµ¿ À̵¿(áôÔÑì¹ÔÑ)
  • phase transfer
    »óÀüÀÌ(ßÓï®ì¹)
  • phosphate group transfer
    Àλê±â ÀüÀÌ(×òß«Ðñï®ì¹)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphoryl-group transfer
    ÀλêÈ­±â ÀüÀÌ(×òß«ûùÐñï®ì¹)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transfer
    Àü´Þ, ÀüÀÌ, Àü¼ÛÇÏ´Ù
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PDS pain-dysfunction syndrome; paroxysmal depolarizing shift; patient data system; Patient-Doctor Societ...
PMP pain management program; patient management program; patient medication profile; peripheral myelin p...
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
ET   1) Essential Thrombocytosis
  2) Embryo Transfer
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OPD Out-Patient Department
OP Out-patient
p Patient
PCS Patient Classification System
PCA Patient Controlled Analgesia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • transfer factor
    Àü´Þ ÀÎÀÚ, ÀüÀÌ ¿äÀÎ
  • transfer RNA
    Àü´Þ RNA
  • adipose patient
    Áö¹æ¼º ȯÀÚ
  • aging patient
    °í·É ȯÀÚ
  • between-patient variability
    ȯÀÚ°£ º¯È­
  • doctor-patient relationship
    ÀÇ»ç-ȯÀÚ °ü°è, ÀÇ»ç ȯÀÚ ½Å·Ú °ü°è
  • dying patient
    ÀÓÁ¾ ȯÀÚ
  • elderly patient
    ³ëÀΠȯÀÚ
  • first-time dental patient
    óÀ½ ³»¿øÇÑ È¯ÀÚ
  • in-patient general anesthesia
    ÀÔ¿ø Àü½Å ¸¶Ãë
  • neurotic patient
    ½Å°æÁõ ȯÀÚ
  • non-patient
    ºñȯÀÚ
  • out-patient general anesthesia
    ¿Ü·¡ Àü½Å ¸¶Ãë
  • patient
    ȯÀÚ
    1. ÀÇÇÐÀû Ä¡·á¸¦ ¹Þ°í ÀÖ´Â »ç¶÷, ƯÈ÷ º´¿ø¿¡¼­. 2. ÀÇ»ç, Ä¡°ú ÀÇ»ç µî¿¡ µî·ÏµÇ¾î Çʿ信 µû¶ó ±×¿¡°Ô Ä¡·á¸¦ ¹Þ´Â »ç¶÷.
  • patient charting
    ȯÀÚ Ã­Æ® ÀÛ¼º
    ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á¿¡ ÇÊ¿äÇÑ ÀûÀýÇÑ Á¤º¸¸¦ ±â·Ï, ÀÛ¼ºÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
patient escort service A special service provided by volunteers to accompany patients who need help in moving about the health facility.
(12 Dec 1998)
patient identification systems Organised procedures for establishing patient identity, including use of bracelets, etc.
(12 Dec 1998)
patient isolation The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.
(12 Dec 1998)
patient isolators Equipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients.
(12 Dec 1998)
patient participation Patient involvement in the decision-making process in matters pertaining to health.
(12 Dec 1998)
patient readmission Subsequent admissions of a patient to a hospital or other health care institution for treatment.
(12 Dec 1998)
patient satisfaction The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.
(12 Dec 1998)
patient selection Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.
(12 Dec 1998)
patient simulation The use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel.
(12 Dec 1998)
Patient Zero The individual identified in 1982 by the Centres for Disease Control as responsible for introducing the HIV virus into the U.S. Population. A Canadian citisen, Patient Zero was a homosexual airline steward who claimed to have had as many as 2,500 sexual encounters. CDC epidemiologists located 19 men in Los Angeles, 22 in New York City, and 8 in other cities who had contracted AIDS from contact with Patient Zero, the earliest known cases of the disease in the U.S. Revealed to be Gaetan Dugas, Patient Zero died in 1984 due to AIDS-related illness.
(05 Mar 2000)
risk patient Patient who is at risk, because of his/her behaviour or because of the type of person he/she is.
(18 Nov 1997)
physician-patient relations The interactions between physician and patient.
(12 Dec 1998)
continuity of patient care Health care provided on a continuing basis from the initial contact with a physician or clinic and following the patient through all episodes of his medical care needs.
(12 Dec 1998)
professional-patient relations Interactions between health personnel and patients.
(12 Dec 1998)
progressive patient care Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organised home care.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transfer
    ¿Å´Ù;ÀüÀԵǴÙ;°¥¾ÆÅ¸´Ù
  • transfer
    ¿Å±â´Ù;³ª¸£´Ù;¾çµµÇÏ´Ù;Àü»çÇÏ´Ù;ÀüÀÓ½ÃŰ´Ù
  • transfer RNA
    ÀüÀÌ RNA;¿î¹Ý RNA
  • transfer company
    ±Ù°Å¸® ¿î¼Ûȸ»ç(µÎ Å͹̳Π¿ª ±¸°£ µî)
  • transfer table
    (Áö»ó½Ä)õÂ÷´ë
  • transfer tax
    »ó¼Ó¼¼;¾çµµ¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á